Bicycle Therapeutics trades below net cash, reflecting market skepticism on future cash burn and delayed commercialization.
Finally, current quality-of-life tools do not fully capture the patient experience. Emerging approaches incorporating patient ...
(UroToday.com) The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was host to a kidney and bladder cancers poster session. Dr. David Cade presented LUTEON, an ongoing phase III trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results